Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Abhishek Rishikesh Teeluck"'
Autor:
Pravesh Kumar Bundhun, Girish Janoo, Akash Bhurtu, Abhishek Rishikesh Teeluck, Mohammad Zafooruddin Sani Soogund, Manish Pursun, Feng Huang
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Nowadays, the total number of couples visiting an infertility clinic is on the rise. Tobacco smoking is considered one of the major factors leading to male infertility. In this study, we aimed to systematically investigate the imp
Externí odkaz:
https://doaj.org/article/c7fa13098ffe4e3e91939aac2a2e045e
Publikováno v:
BMC Pharmacology and Toxicology, Vol 18, Iss 1, Pp 1-10 (2017)
Abstract Background Vildagliptin and pioglitazone/rosiglitazone are emerging Oral Hypoglycemic Agents (OHAs) which are used to treat patients suffering from Type 2 Diabetes Mellitus (T2DM). In this analysis, we aimed to systematically compare the adv
Externí odkaz:
https://doaj.org/article/c8445c5b4b7a4304be3ba8cf21055cd6
Autor:
Pravesh Kumar Bundhun, Akash Bhurtu, Manish Pursun, Mohammad Zafooruddin Sani Soogund, Abhishek Rishikesh Teeluck, Wei-Qiang Huang
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-18 (2017)
Abstract Several previously published trials comparing Zotarolimus Eluting Stents (ZES) with Sirolimus Eluting Stents (SES), Paclitaxel Eluting Stents (PES) or Everolimus Eluting Stents (EES) at a follow up period of 1 year, were continually being fo
Externí odkaz:
https://doaj.org/article/eb4f01da6094445ea7f0f662ef0f90f9
Autor:
Manish Pursun, Akash Bhurtu, Abhishek Rishikesh Teeluck, Pravesh Kumar Bundhun, Girish Janoo, Feng Huang, Mohammad Zafooruddin Sani Soogund
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-11 (2019)
BMC Public Health
BMC Public Health
Background Nowadays, the total number of couples visiting an infertility clinic is on the rise. Tobacco smoking is considered one of the major factors leading to male infertility. In this study, we aimed to systematically investigate the impact of to
Publikováno v:
BMC Pharmacology and Toxicology, Vol 18, Iss 1, Pp 1-10 (2017)
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology
Background Vildagliptin and pioglitazone/rosiglitazone are emerging Oral Hypoglycemic Agents (OHAs) which are used to treat patients suffering from Type 2 Diabetes Mellitus (T2DM). In this analysis, we aimed to systematically compare the adverse drug
Autor:
Akash Bhurtu, Abhishek Rishikesh Teeluck, Manish Pursun, Wei-Qiang Huang, Pravesh Kumar Bundhun, Mohammad Zafooruddin Sani Soogund
Publikováno v:
BMC Cardiovascular Disorders
Background Warfarin is commonly used as a secondary prevention of stroke in patients with atrial fibrillation (AF). However, limitations have been observed even with the use of this medication. Recently, several newer direct oral anticoagulants (DOAC
Autor:
Akash Bhurtu, Manish Pursun, Pravesh Kumar Bundhun, Abhishek Rishikesh Teeluck, Wei-Qiang Huang, Mohammad Zafooruddin Sani Soogund
Publikováno v:
Scientific Reports
This study aimed to compare the mid-term adverse cardiovascular outcomes associated with Coronary Artery Bypass Surgery (CABG) and Percutaneous Coronary Intervention (PCI) with Everolimus Eluting Stents (EES). Electronic databases were searched for s
Publikováno v:
BMC Cardiovascular Disorders
Background Guidelines from the American Heart Association/American College of Cardiology recommend a higher dosage of aspirin daily following Percutaneous Coronary Intervention (PCI), whereas guidelines from the European Society of Cardiology recomme
Publikováno v:
Medicine. 95:e3276
Controversies still exist with the use of Everolimus-Eluting Stents (EES) compared to other Drug-Eluting Stents (DES) in patients with Type 2 Diabetes Mellitus (T2DM). Therefore, in order to solve this issue, we aim to compare the 1-year adverse clin